018769376

REGENECYTE

---

September 27, 2022

Trademark Summary

The trademark application REGENECYTE was filed by StemCyte, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 24, 2022, and it was registered by office on January 31, 2023 without any oppositions.

The application was filed in English (Italian was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with pharmaceutical cord blood preparations for autologous transplantation, allogeneic transplantation, and human transplant uses derived from human cord blood.